Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

Keeping Current CME

English - December 14, 2023 19:50 - 18 minutes - 25.5 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

Next Episode: Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations

Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing?

Credit available for this activity expires: 12/13/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu